In vitro comparison of antiviral drugs against feline herpesvirus 1

被引:36
|
作者
Van Der Meulen K. [1 ]
Garré B. [1 ,2 ]
Croubels S. [2 ]
Nauwynck H. [1 ]
机构
[1] Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke
[2] Department of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke
关键词
Acyclovir; Ganciclovir; Antiviral Drug; Adefovir; Cidofovir;
D O I
10.1186/1746-6148-2-13
中图分类号
学科分类号
摘要
Background: Feline herpesvirus 1 (FHV-1) is a common cause of respiratory and ocular disease in cats. Especially in young kittens that have not yet reached the age of vaccination, but already lost maternal immunity, severe disease may occur. Therefore, there is a need for an effective antiviral treatment. In the present study, the efficacy of six antiviral drugs, i.e. acyclovir, ganciclovir, cidofovir, foscarnet, adefovir and 9-(2- phosphonylmethoxyethyl)-2, 6-diaminopurine (PMEDAP), against FHV-1 was compared in Crandell-Rees feline kidney (CRFK) cells using reduction in plaque number and plaque size as parameters. Results: The capacity to reduce the number of plaques was most pronounced for ganciclovir, PMEDAP and cidofovir. IC 50 (NUMBER) values were 3.2 μg/ml (12.5 μM), 4.8 μg/ml (14.3 μM) and 6 μg/ml (21.5 μM), respectively. Adefovir and foscarnet were intermediately efficient with an IC50 (NUMBER) of 20 μg/ml (73.2 μM) and 27 μg/ml (140.6 μM), respectively. Acyclovir was least efficient (IC50 (NUMBER) of 56 μg/ml or 248.7 μM). All antiviral drugs were able to significantly reduce plaque size when compared with the untreated control. As observed for the reduction in plaque number, ganciclovir, PMEDAP and cidofovir were most potent in reducing plaque size. IC50 (SIZE) values were 0.4 μg/ml (1.7 μM), 0.9 μg/ml (2.7 μM) and 0.2 μg/ml (0.7 μM), respectively. Adefovir and foscarnet were intermediately potent, with an IC50 (SIZE) of 4 μg/ml (14.6 μM) and 7 μg/ml (36.4 μM), respectively. Acyclovir was least potent (IC 50 (SIZE) of 15 μg/ml or 66.6 μM). The results demonstrate that the IC50 (SIZE) values were notably lower than the IC 50 (NUMBER) values. The most remarkable effect was observed for cidofovir and ganciclovir. None of the products were toxic for CRFK cells at antiviral concentrations. Conclusion: In conclusion, measuring reduction in plaque number and plaque size are two valuable and complementary means of assessing the efficacy of an antiviral drug. By using these parameters for six selected antiviral drugs, we found that ganciclovir, PMEDAP, and cidofovir are the most potent inhibitors of FHV-1 replication in CRFK cells. Therefore, they may be valuable candidates for the treatment of FHV-1 infection in cats. © 2006 van der Meulen et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolites
    Groth, Allyson D.
    Contreras, Marcos T.
    Kado-Fong, Helen K.
    Nguyen, Kyvan Q.
    Thomasy, Sara M.
    Maggs, David J.
    VETERINARY OPHTHALMOLOGY, 2014, 17 (04) : 268 - 274
  • [2] A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1)
    Pennington, Matthew R.
    Fort, Michael W.
    Ledbetter, Eric C.
    Van de Walle, Gerlinde R.
    JOURNAL OF GENERAL VIROLOGY, 2016, 97 : 1414 - 1425
  • [3] In vitro efficacy of ganciclovir against feline herpesvirus type 1 and assessment of ocular tolerability in healthy cats
    Lewin, Andrew C.
    Liu, Chin-Chi
    Alling, Christopher
    Camacho-Luna, Pilar
    Miessler, Bruna
    Carter, Renee T.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2021, 23 (04) : 400 - 404
  • [4] Antiviral Therapy for Feline Herpesvirus Infections
    Maggs, David J.
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2010, 40 (06) : 1055 - +
  • [5] Surveillance for feline herpesvirus type 1 mutation and development of resistance in cats treated with antiviral medications
    Lewin, Andrew C.
    Ineck, Nikole E.
    Mironovich, Melanie A.
    Marino, Morgan E.
    Liu, Chin-Chi
    Emelogu, Ugochi
    Mills, Erinn P.
    Camacho-Luna, Pilar
    Carter, Renee T.
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [6] In vitro antiviral activity of Ficus carica latex against caprine herpesvirus-1
    Camero, Michele
    Marinaro, Mariarosaria
    Lovero, Angela
    Elia, Gabriella
    Losurdo, Michele
    Buonavoglia, Canio
    Tempesta, Maria
    NATURAL PRODUCT RESEARCH, 2014, 28 (22) : 2031 - 2035
  • [7] In vitro activity of six antiviral drugs against equid alphaherpesvirus type 1 indicates ganciclovir as promising drug for in vivo studies
    de Oliveira, Amanda Lovato
    Cargnelutti, Juliana Felipetto
    Gnocato Mortari, Ana Paula
    Flores, Eduardo Furtado
    Weiblen, Rudi
    CIENCIA RURAL, 2018, 48 (12):
  • [8] Herpesvirus resistance to antiviral drugs: A review of the mechanisms, clinical importance and therapeutic options
    Reusser, P
    JOURNAL OF HOSPITAL INFECTION, 1996, 33 (04) : 235 - 248
  • [9] Evaluation of the effects of small interfering RNAs on in vitro replication of feline herpesvirus-1
    Wilkes, Rebecca P.
    Kania, Stephen A.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2010, 71 (06) : 655 - 663
  • [10] Clinical evaluation of antiviral combination treatment in cats with feline herpesvirus-1 infection
    Ozkanlar, Y.
    Ulas, N.
    Sozdutmaz, I.
    Ozkanlar, S.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2023, 26 (04): : 705 - 713